Treace Medical Concepts (TMCI) Notes Payables (2025 - 2026)
Treace Medical Concepts (TMCI) posted Notes Payables of $1.8 million for Q1 2026, up 1.78% on a QoQ basis from $1.7 million in Q4 2025, and up 3846.67% year-over-year from $45000.0 in Q1 2025.
Treace Medical Concepts (TMCI) Notes Payables (2025 - 2026) Analysis & Trends
Treace Medical Concepts' Notes Payables history runs 2 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- Quarterly Notes Payables rose 3846.67% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 3846.67% YoY) and the FY2025 annual result came in at $1.7 million, changed N/A from the prior year.
- Notes Payables was $1.8 million for Q1 2026 at Treace Medical Concepts, up from $1.7 million in the prior quarter.
- Across five years, Notes Payables topped out at $1.8 million in Q3 2025 and bottomed at $45000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Treace Medical Concepts | 262.89 Mn | 211.04 Mn | 37.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 1.80 Mn |
| Jun 30, 2025 | 1.11 Mn |
| Mar 31, 2025 | 45,000.00 |